Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics

被引:62
作者
Bois, FY [1 ]
机构
[1] INERIS, F-60550 Verneuil En Halatte, France
关键词
Bayesian; human; Markov chain Monte Carte; mouse; PBPK model; rat; TCE; toxicokinetics; tricholoroethylene; uncertainty analysis;
D O I
10.1289/ehp.00108s2307
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A physiologically based pharmacokinetic model for trichloroethylene (TCE) in rodents and humans was calibrated with published toxicokinetic data sets. A Bayesian statistical framework was used to combine previous information about the model parameters with the data likelihood, to yield posterior parameter distributions. The use of the hierarchical statistical model yielded estimates of both variability between experimental groups and uncertainty in TCE toxicokinetics. After adjustment of the model by Markov chain Monte Carlo sampling, estimates of variability for the animal or human metabolic parameters ranged from a factor of 1.5-2 (geometric standard deviation [GSD]). Uncertainty was of the same order as variability for animals and higher than variability for humans. The model was used to make posterior predictions for several measures of cancer risk. These predictions were affected by both uncertainties and variability and exhibited GSDs ranging from 2 to 6 in mice and rats and from 2 to 10 for humans.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 47 条
[1]  
ASTRAND I, 1976, SCAND J WORK ENV HEA, V4, P199
[2]   Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics [J].
Bois, FY .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :275-282
[3]   Population toxicokinetics of benzene [J].
Bois, FY ;
Jackson, ET ;
Pekari, K ;
Smith, MT .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 :1405-1411
[4]   Population toxicokinetics of tetrachloroethylene [J].
Bois, FY ;
Gelman, A ;
Jiang, J ;
Maszle, DR ;
Zeise, L ;
Alexeef, G .
ARCHIVES OF TOXICOLOGY, 1996, 70 (06) :347-355
[5]  
BOIS FY, 1997, J STAT SOFTWARE
[6]   Physiologically based pharmacokinetic modeling as a tool for drug development [J].
Charnick, SB ;
Kawai, R ;
Nedelman, JR ;
Lemaire, M ;
Niederberger, W ;
Sato, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (02) :217-229
[7]   Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment [J].
Clewell, HJ ;
Gentry, PR ;
Covington, TR ;
Gearhart, JM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :283-305
[8]  
Davidian M., 1995, NONLINEAR MODELS REP
[9]  
FANNING E, 1997, SOC TOXICOLOGY ANN M
[10]  
FERNANDEZ JG, 1977, BRIT J IND MED, V34, P43